Spelling suggestions: "subject:"nonsmooth"" "subject:"monsmooth""
11 |
Epigenetic regulation of smooth muscle function in inflammatory responsesSalinthone, Sonemany. January 2006 (has links)
Thesis (Ph. D.)--University of Nevada, Reno, 2006. / "August, 2006." Includes bibliographical references (leaves 214-226). Online version available on the World Wide Web.
|
12 |
Endothelial dysfunction and changes in vascular smooth muscle responsiveness in femoral arteries of rats with type I diabetes /Shi, Yi, January 2006 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2007. / Also available online.
|
13 |
The effect of DHA and EPA on fibrosis-related factors in vascular cellsWhyte, Claire Susan. January 2009 (has links)
Thesis (Ph.D.)--Aberdeen University, 2009. / Title from web page (viewed on July 1, 2009). Includes bibliographical references.
|
14 |
A study of the relationship of mechanical to electrical activity in smooth muscleAxelsson, J. January 1965 (has links)
No description available.
|
15 |
Relationship between cyclic AMP-dependent protein kinase activation and smooth muscle relaxation by cyclic AMP and analogsMacDonell, Karen Loraine January 1991 (has links)
It is generally held that adenosine 3',5'-cyclic monophosphate (cAMP) mediates smooth muscle relaxation by the activation of cAMP-dependent protein kinase (PKA). This hypothesis was tested in two intact smooth muscle preparations, the rat vas deferens and the bovine coronary artery, using exogenously applied cAMP and cAMP analogs.
After 30 minutes of incubation, N⁶,2'-0-dibutyryl-cAMP (dBu-cAMP) (1 - 100 μM) inhibited phenylephrine (PE)-induced tension generation in the rat vas deferens in a dose-dependent manner. This analog (10 μM) also activated the soluble fraction of PKA but did not activate the particulate fraction kinase. In contrast, 8-bromo-cAMP (8Br-cAMP) (10 -100 μM) did not have any significant effect on inhibition of PE-induced tension after 30 minutes of incubation but, at a concentration of 10 μM, significantly activated both the soluble and particulate fractions of PKA. The time course of activation of soluble PKA activation by 8Br-cAMP (10 μM) demonstrated that the kinase was significantly activated only after 30 minutes of exposure to the analog.
In the bovine coronary artery, cAMP (10 - 100 μM) relaxed potassium-depolarized helical strips and significantly activated soluble PKA in a dose-dependent manner. dBu-cAMP (10 - 100 μM) affected neither tension nor soluble PKA activity. 8Br-cAMP (10 - 100 μM) did not affect the coronary artery tension but did activate soluble PKA.
Both smooth muscle preparations were homogenized with charcoal prior to the determination of PKA activity in order to minimize artifactual assay results. As a further precaution, extracellularly associated cAMP and analogs were also washed from bovine coronary artery strips after the incubation period. These controls allowed for a valid assessment of PKA activity in the cyclic nucleotide-treated tissues.
The results of the tension and kinase studies demonstrate a lack of correlation between activation of PKA and inhibition of rat vas deferens contraction or relaxation of bovine coronary artery. This does not support the hypothesis that the kinase is responsible for cAMP-induced relaxation of vascular and non-vascular smooth muscle. While the mechanism by which exogenous cAMP and specific analogs induce relaxation in some smooth muscle preparations remains unclear, it can be suggested that PKA activation is not necessarily required for the final functional effect. / Medicine, Faculty of / Anesthesiology, Pharmacology and Therapeutics, Department of / Graduate
|
16 |
On the nature of the reversal of Mg2+-induced vascular relaxation byL-Name, a nitric oxide synthase inhibitorDas, Rapti. January 1996 (has links)
published_or_final_version / Physiology / Master / Master of Philosophy
|
17 |
Modulation of vascular response by equol劉展彤, Lau, Chin-tung. January 2008 (has links)
published_or_final_version / Pharmacology / Master / Master of Research in Medicine
|
18 |
The role of cadherins in vascular diseaseUglow, Elizabeth January 2002 (has links)
No description available.
|
19 |
The theoretical and numerical analysis of impact oscillatorsLee, Gordon January 1996 (has links)
No description available.
|
20 |
Neurotransmission in the lower urinary tractTempleman, Lucy A. January 2002 (has links)
No description available.
|
Page generated in 0.0292 seconds